In Mouse Model, Promising Alzheimer's 'Drug' Halts Memory Loss

A new class of experimental drug-like small molecules is showing great promise in targeting a brain enzyme to prevent early memory loss in Alzheimer’s disease, according to Northwestern Medicine® research. Developed in the laboratory of D. Martin Watterson, the molecules halted memory loss and fixed damaged communication among brain cells Read & Research Alzheimer’s More

Leave a Reply